You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Finland

Jun 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Finland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Finland, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Finland for free:

The Consumer Health in Finland market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Finland?
  • What are the major brands in Finland?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Healthy growth despite the challenging economy

Consumer health products not only continued to be necessities, but also saw increased demand. Growth improved slightly in 2010 in comparison with the previous year, as consumers regained their purchasing confidence in light of hopes for a better economy. Although the market in general can be considered as already maturing, some categories witnessed dynamic growth rates, whilst others faced lagging demand or even declining sales. Also, VAT changed in 2010, as the VAT on medicine was increased from 8% to 9%, and the VAT on dietary supplements increased from 12% to 13% in July 2010.

Critical consumer groups invest in consumer health

With or without recession, consumers needed to purchase healthcare products. Whilst some consumers were forced to down-trade in 2010, and familiarised themselves with private label products and generics, consumers who were not affected by the recession were ready to invest. Overall, the health and wellbeing trend continued to be strong in 2010. Nonetheless, it mattered to consumers what they purchased, as price, quality and suitability were often compared. Also, heavily advertised products, as well as more sophisticated products, received a great deal of attention.

Companies cater to consumer trends

Strong competition and a maturing market made companies consider their moves carefully. Investing in new product developments and advertising in order to stand out and boost sales was a widely-used strategy. Manufacturers did not only launch more sophisticated products in different delivery formats and attractive packaging, but also adapted to wider consumer trends, such as organic products. As a result, more natural, organic products without artificial additives, sweeteners, colourings or preservatives entered the market. Also, scientific studies were used to promote brands and to increase consumer awareness.

Chemists/pharmacies is still the biggest distribution channel, but is challenged

Despite the fact that chemists/pharmacies led the distribution of consumer health products in Finland in 2010, this channel has been losing its foothold. A significant amount of NRT cessation aids, vitamins and dietary supplements, sports nutrition, wound care and weight management products are purchased through other channels, such as grocery retailers, gyms, other healthcare specialist retailers, and, in increasing amounts, through internet retailing. This is due to convenience, as consumers find it handy to shop for their healthcare products whilst grocery shopping or working out in a sports centre or gym.

Maturity is a challenge

Market maturity remains the biggest challenge to value sales in consumer health, which companies will have to confront. Still, some categories will continue to see good, if not dynamic growth, due to their novelty or increased demand. Changes in the Finnish population, such as the rapidly increasing older population and increased immigration, will contribute to sales. Also, already high allergy and obesity levels are predicted to continue to increase, pushing the demand for some products. Consumer lifestyles are often stressful, with unhealthy diet, too little exercise and increasing worries about health and wellbeing, which will also help to push sales.

Table of Contents

Table of Contents

Consumer Health in Finland - Industry Overview

EXECUTIVE SUMMARY

Healthy growth despite the challenging economy

Critical consumer groups invest in consumer health

Companies cater to consumer trends

Chemists/pharmacies is still the biggest distribution channel, but is challenged

Maturity is a challenge

KEY TRENDS AND DEVELOPMENTS

From recession towards recovery

Demographic changes shape consumer health

Market maturity is a challenge

Obesity as an epidemic, and its significance in boosting sales

  • Table 1 Percentage of Overweight Boys 1977/2003
  • Table 2 Percentage of Overweight Girls 1977/2003

Distribution channels are in heavy competition

MARKET INDICATORS

  • Table 3 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 4 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 5 Sales of Consumer Health by Category: Value 2005-2010
  • Table 6 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 7 Consumer Health Company Shares by Value 2006-2010
  • Table 8 Consumer Health Brand Shares by Value 2007-2010
  • Table 9 Penetration of Private Label by Category 2005-2010
  • Table 10 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 11 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 12 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 13 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

Sources

  • Summary 2 Research Sources

Consumer Health in Finland - Company Profiles

Leiras Finland Oy Ab in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Leiras Finland Oy Ab: Competitive Position 2010

Orion Oyj in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Orion Oyj: Competitive Position 2010

Suomen Bioteekki Oy in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Suomen Bioteekki Oy: Competitive Position 2010

Valioravinto Oy Ab in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Valioravinto Oy Ab: Competitive Position 2010

Vitabalans Oy in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Vitabalans Oy: Competitive Position 2010

Adult Mouth Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care increased by 2% in current value terms to reach €2 million in 2010. The category faced strong competition from widely marketed and advertised traditional oral care products. In fact, improvements in traditional oral care products such as toothpaste, mouthwashes and dental rinses subsequently undermined demand for adult mouth care. Sales of standard oral care products are worth double that of their consumer health equivalents. Also, a lack of marketing of OTC products hindered growth, and consumers find it difficult to see how OTC products differ from the traditional oral care products available in supermarkets. Most Finns find mainstream oral care products, such as toothpaste and floss, to be sufficient. In addition, as toothpaste and toothbrushes have become ever more sophisticated, the interest in adult mouth care has not expanded, despite a growing interest in oral care in Finland. Instead, adult mouth care is mostly used in “emergency” situations, for example to treat gum infections.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline dominated adult mouth care with a 73% share of value sales in 2010, due to its well-known Corsodyl brand. The brand has a strong image, and has become popular over the years through advertising campaigns.

PROSPECTS

  • Adult mouth care is predicted to increase by a CAGR of 1% in constant value terms in the forecast period 2010-2015, to reach sales of €2 million in 2015. Growth rates will remain low, hindered by maturity, little activity from manufacturers and competition from standard oral care products. Nonetheless, the positive, albeit stagnant growth, will come from increasing health and wellness concerns, as well as the ageing population, which will help to increase sales slightly.

CATEGORY DATA

  • Table 14 Sales of Adult Mouth Care: Value 2005-2010
  • Table 15 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 16 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 17 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 18 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 19 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Finland - Category Analysis

HEADLINES

TRENDS

  • Analgesics increased by a healthy 4% in current value terms in 2010, with sales reaching €78 million. Growth was driven by the increased use of analgesics, as well as the ageing population. However, the popularity of different analgesics varied across the category, as some products were considered to be old-fashioned and declined in current value terms, whilst others grew dynamically. Aspirin and ketoprofen, for instance, continued to lose sales, especially to ibuprofen, including amongst the ageing population. Child-specific products increased in popularity, as did topical analgesics/anaesthetic. Parents preferred purchasing products specifically meant for children, rather than using lower doses of traditional brands.

SWITCHES

COMPETITIVE LANDSCAPE

  • Orion continued to be the leader in analgesics with a 50% share of value sales in 2010. Its leading position is due to the company’s long presence in Finland and its popular and well-known Burana brand, which has become a household name. The company’s products enjoy prime shelf positioning, and benefit from nationwide distribution. Its product portfolio also includes several formats, from tablets and effervescent to child-specific formats, and also widely-known brands of topical analgesics/anaesthetics, such as Ketorin and Trombosol Forte. Finns trust the company’s brands, and have remained loyal to them over the years.

PROSPECTS

  • Analgesics is predicted to see a constant value CAGR of 2% in the forecast period 2010-2015, reaching sales of €85 million in 2015. This growth will be mostly due to the increasing elderly population in Finland, as well as slightly increasing individual use. Demand for more premium products and demand in still underdeveloped categories such as topical analgesics/anaesthetic and child-specific analgesics are also expected to boost sales. Also, new product launches and advertising, which are expected to continue intensively, will push sales.

CATEGORY DATA

  • Table 20 Sales of Analgesics by Category: Value 2005-2010
  • Table 21 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 22 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 23 Analgesics Company Shares by Value 2006-2010
  • Table 24 Analgesics Brand Shares by Value 2007-2010
  • Table 25 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 26 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Finland - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products increased by a healthy 3% in current value terms, reaching sales of €5 million in 2010. Busy and hectic lifestyles provoked stress and sleeping problems, which encouraged consumers to look for ways to relax by using herbal calming and sleeping products in Finland. Due to their herbal ingredients, consumers view them as rather harmless, and are willing to try them out. Also, awareness of these products continued to increase, bringing more customers to the category.

SWITCHES

COMPETITIVE LANDSCAPE

  • Orion led calming and sleeping products with a 39% share of value sales in 2010. This domestic company is well-known and trusted amongst consumers; it has a well-organised distribution network and efficient sales department, which managed to boost its sales. Its Sedonium brand is available at chemists/pharmacies. The brand has its own website, www.sedonium.fi, and was also advertised on television and on the radio, which helped to push its sales.

PROSPECTS

  • Calming and sleeping products is predicted to increase by a constant value CAGR of 2% in the forecast period 2010-2015, reaching sales of €6 million. The growth in sleeping disorders in Finland, as well as greater consumer intent to correct this with less harmful herbal calming and sleeping products, will boost growth in the category. Also, the growing elderly population, which has been pointed out as having sleeping problems, will contribute to growth. According to a study published in the Finnish Medical Journal (Suomen Lääkärilehti 16/2008), 10% of the total population in Finland suffer from some sort of sleeping disorder every day or almost every day; a problem which is steadily increasing. Increasing stress and irregular working hours are the main reasons believed to lie behind this trend.

CATEGORY DATA

  • Table 27 Sales of Calming and Sleeping: Value 2005-2010
  • Table 28 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 29 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 30 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 31 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 32 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Finland - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy remedies increased by 2% in current value terms in 2010, with sales reaching €61 million. Switches of allergy remedies from Rx status to OTC status helped to push sales, as did the swine flu and the very cold winter.

SWITCHES

COMPETITIVE LANDSCAPE

  • Orion led cough, cold and allergy (hay fever) remedies in 2010, holding a 20% share of value sales. The company’s leadership is largely due to its solid position in cough remedies, in which it controls the three leading brands: Medipekt, Reodyn and Resilar. These brands are popular mainly because they have been on the market for a long time, and thus are well-known and trusted by most Finns. Moreover, Orion’s products have national coverage and hold prime shelf positioning. In 2010 this domestic company managed to increase its share to a stronger 20%. This was the result of advertising campaigns on national television, billboards and in magazines, mainly of its Nasolin brand (advertised as a preservative-free product), which strengthened the company’s position.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is predicted to increase by a negligible positive constant value CAGR in the forecast period 2010-2015, to reach sales of €63 million in 2015. Although the category is no longer young, some less mature and more dynamic categories will continue to push sales, such as nasal decongestants. However, the category will have to fight against more affordable generics, which may hinder value sales growth. Nonetheless, consumers are expected to react well to intense advertising campaigns, as well as to invest in efficient cough, cold and allergy remedies.

CATEGORY DATA

  • Table 33 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 34 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 35 Sales of Decongestants by Category: Value 2005-2010
  • Table 36 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Finland - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies increased by a dynamic 9% in current value terms in 2010, with sales reaching €56 million. New launches and switches to OTC status boosted sales. Consumer awareness also increased, as active advertising campaigns pushed sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • Janssen-Cilag continued to lead digestive remedies with a 22% share of value sales in 2010. This position was primarily due to a large number of brands, such as Vi-Siblin, Pepcid, Imodium and Microlax, rather than one specific giant brand. The company also managed to increase its share from less than 22% in 2009 to over 22% in 2010, by nearly half a percentage point. This was the result of its Pepcid brand being heavily advertised on television.

PROSPECTS

  • Digestive remedies is expected to see a constant value CAGR of 2% in the forecast period 2010-2015, climbing to sales of €62 million in 2015. This positive growth will be brought about by increasing awareness of digestive remedies, advertising, new product launches, the ageing population, growing stress levels and increasing obesity amongst the population.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Ear care saw 2% current value growth and reached sales of €300,000 in 2010. There are only two brands available in ear care, which both keep the ear canals clear from ear wax. Only a limited number of consumers feel the need to purchase these products. Products to treat more serious ear infections are not available as OTC medicines, which meant that more acute health issues had to be solved through a doctor.

SWITCHES

COMPETITIVE LANDSCAPE

  • The domestic company Orion retained its leading position in ear care with a 58% value share in 2010. This position was due to its Remo-Wax brand. The multinational UCB Pharma Finland held a 42% share of value sales thanks to its Oroclean brand.

PROSPECTS

  • Ear care is predicted to reach sales of €300,000 in 2015, after increasing by 1% in CAGR terms. Due to the small product selection and slowly growing customer base, ear care in Finland is facing stagnation.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Finland - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception increased by 2% in current value terms, reaching sales of €2 million in 2010. Growing sales were the result of better awareness of the availability of emergency contraception. It should be pointed out that emergency contraception was often also purchased to be kept within reach just in case it was needed.

SWITCHES

COMPETITIVE LANDSCAPE

  • Leiras Finland remained the only company present in emergency contraception, with a 100% share of value sales in 2010 with its brand NorLevo. NorLevo was first launched in Finland in 2000, although at that point it was only available on prescription. In January 2002 the National Agency for Medicines (NAM), nowadays known as the Finnish Medicines Agency or FIMEA, decided to switch NorLevo, which has since been available as an OTC medicine through chemists/pharmacies. Since the switch, information campaigns have been conducted through leaflets, which have increased awareness of the product.

PROSPECTS

  • Emergency contraception is expected to see a CAGR of 1% in constant value terms over the forecast period 2010-2015, remaining at sales of €2 million in 2015. Women are expected to continue purchasing the product not only to be used immediately, but also to be stored for an emergency at home.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2005-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Eye care increased by 2% in current value terms in 2010, reaching sales of €6 million. This was a result of the increasing occurrence of dry eye symptoms and allergies. The ageing population and growing use of contact lenses, as well as computers, also contributed to growth. Moreover, these products were also actively advertised, drawing consumers’ attention to product availability.

SWITCHES

COMPETITIVE LANDSCAPE

  • Santen led eye care in 2010 with a 33% share of value sales. Santen’s lead was a result of its popular Lecrolyn and Oftagel brands, but the company also has a number of other smaller brands in its portfolio, such as Oftan and Artelac. These brands offer a good selection of products, which are also well advertised and benefit from good nationwide distribution.

PROSPECTS

  • Eye care is predicted to see a constant value CAGR of 1% in the forecast period 2010-2015, reaching sales of €6 million in 2015. However, growth will be positive, as the ageing population will lead to growth. Moreover, allergy levels may still increase, as well as the incidence of dry eyes, due to the use of contact lenses, longer time spent in front of computers and even the slowly rising popularity of laser vision corrective surgery. These factors are likely to increase value sales slowly.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Finland - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products saw 3% current value growth in 2010, reaching sales of €46 million. Herbal/traditional dietary supplements was the biggest category. Advertising and new product launches, supported by scientific studies in some cases, helped to increase sales. Consumers compared prices and ingredients in order to achieve good value for money purchases. Herbal/traditional remedies were also used not only on their own, but at times also combined with standard OTC medicinal treatments in order to achieve the best results. In particular, herbal dietary supplements were popular, as consumers became increasingly worried about their wellbeing. Also, all calming and sleeping OTC products are herbal in Finland, since non-herbal products are only available with a prescription. Many Finns are reluctant to use prescription-based sleeping products, which explains the growing demand for herbal alternatives.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products is rather fragmented, with a large number of players present. Nonetheless, Procter & Gamble Finland remained in the leading position with a 16% share of value sales in 2010.This position is due to its popular Vicks brand in herbal/traditional cough, cold and allergy (hay fever) remedies, which also led overall herbal/traditional remedies. Vicks benefits from being widely available in the grocery retail channel, and the fact that it has been on the market for a long time.

PROSPECTS

  • Herbal/traditional products is predicted to increase by a constant value CAGR of 2% in the forecast period 2010-2015, to reach sales of €48 million in 2015. Sales are predicted to expand as distribution improves and internet sales increase. Consumers’ scepticism is also expected to erode slowly, due to the active campaigning of companies, the writing of articles and published results of scientific studies, thus pushing growth. Sales of herbal remedies will, however, remain small.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care increased by 1% in current value terms, reaching sales of €37 million in 2010. The category is already rather mature, and penetration levels are high in Finland. Skin allergy levels are high in Finland, which explains the high penetration of medicated skin care products. According to the Finnish Allergy and Asthma Federation, around 15-20% of Finns suffer from atopic eczema during their lifetime. This continued to push value growth in medicated skin care. In the recession price competition was also more tense, and generic products did well.

SWITCHES

COMPETITIVE LANDSCAPE

  • The domestic company Orion maintained its lead in medicated skin care in 2010, holding a 40% share of value sales. This position was a result of Orion’s strong position in antipruritics and vaginal antifungals. In antipruritics, Orion, with its numerous brands, held a 77% share of retail value sales in 2010. Orion has several popular brands which are well-known and trusted by Finns, including the leading brand Hydrocortison, as well as the third brand Nizoral. Their popularity is due to their long-standing presence in the market and familiarity amongst most Finns. The company also benefits from wide consumer trust, excellent shelf positioning, a good product selection, nationwide distribution and advertising.

PROSPECTS

  • Medicated skin care is predicted to see a negligible positive constant value CAGR in the forecast period 2010-2015, reaching sales of €38 million in 2015. The category is already mature, and companies will have to deal with saturation. Also, the competition in many categories is harsh due to a wide selection of strong brands. Generic products are expected to continue to interest consumers due to their lower prices. Growth, albeit small, will come from the ageing population in Finland, more stressful lifestyles and increasing allergies, as well as growing awareness of and concern about skin care.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Finland - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids increased by 4% in current value terms, reaching €29 million in 2010. Smoking prevalence continued to decline in 2010, as it dropped slightly to 20.0%, from 20.1% in 2009. Social acceptance of smoking and legislation have been growing less tolerant towards smoking. A new law in 2009 prohibited the sale of tobacco packs containing less than 20 sticks, and retailers are now required to hold a sales permission, whilst excise duties pushed prices to increase at a time of economic hardship in the country. Anti-smoking campaigning bore fruit, and turned attitudes towards smoking and smokers more negative. Furthermore, consumers were more aware of their wellbeing, and more concerned about their health, which meant that giving up smoking, although a very slow process, continued to take place. All of these factors contributed to good sales of NRT smoking cessation aids. Also, new launches and advertising, as well as the visible positioning of these products near the tills at grocery retailers, helped to push sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • Janssen-Cilag strengthened its leading position in NRT smoking cessation aids to 54% in 2010, and was followed by Novartis Finland with a 44% value share. The company’s lead resulted mainly from being a pioneer in NRT smoking cessation aids with the Nicorette brand, which gave it first-mover advantage. Nicorette is available in gum, inhalators, patches and microtabs. The brand was promoted in printed media in 2010, and was also extended with a new Nicorette Whitemint version of NRT gum in April 2009. The product was marketed to help treat discolouration of the teeth, and in addition it was sweetened with xylitol, which has been proven to prevent caries, giving the product an even healthier image.

PROSPECTS

  • NRT smoking cessation aids is predicted to increase by a CAGR of 3% in the forecast period 2010-2015 to reach sales of €33 million in 2015. Healthy growth in demand will result from different reasons. Increasing excises, rising prices, tobacco bans, stronger campaigns and increasing health and wellbeing concerns are expected to encourage consumers to turn to NRT smoking cessation aids. Moreover, legislation is likely to become even more intolerant of tobacco products. New legislative proposals include forcing tobacco products under the counter and banning new products from entering the market. In addition, the Finnish government has made it clear that its long-term intention is to stub out smoking in Finland once and for all. As a result, the future seems bright for NRT smoking cessation aids. New launches and advertising campaigns are also predicted to continue to push sales upwards.

CATEGORY INDICATOR

  • Table 81 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 82 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 83 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 84 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 85 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 86 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 88 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Finland - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition increased by 5% in current value terms in 2010, reaching sales of €18 million. Sales were driven not only by the growing fitness culture in Finland, but also by advertising and distribution of sports nutrition products in health and sports centres. A growing proportion of Finns are becoming overweight or obese, which also increased the interest in exercise and visiting the gym, thus also creating new potential consumers of sports nutrition products. Many consumers are looking for an easy way to gain muscle power, which in combination with the image portrayed in the media and fashion industry, also generated stronger interest in these products. Indeed, consumers could choose from a very wide selection of products according to their needs and goals, such as body building or recovery sports nutrition.

COMPETITIVE LANDSCAPE

  • Func Food Finland continued to hold the leading position in sports nutrition in 2010, with a 49% share of value sales. This position was mainly due to a wide array of products, but also due to best-selling brands such as Hera80 and Mass2, which were the top two best-selling brands in sports nutrition in Finland in 2010. Func Food Finland also issues “Gym” magazine, which further supported sales of the company’s brands. Its products also enjoy an excellent distribution network and have prime shelf positioning.

PROSPECTS

  • Sports nutrition is expected to see a constant value CAGR of 3% in the forecast period 2010-2015, reaching sales of €21 million in 2015. Sales will be driven by a growing proportion of the general public interested in body building and more serious sports. Finns are becoming more body-conscious, and the number of amateur body builders is increasing, adding impetus to growth. Finns are predicted to become more tempted by the idea of consuming sports nutrition products, and thus taking a “short cut” in order to gain some muscle weight.

CATEGORY DATA

  • Table 89 Sales of Sports Nutrition: Value 2005-2010
  • Table 90 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 91 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 92 Sports Nutrition Company Shares 2006-2010
  • Table 93 Sports Nutrition Brand Shares 2007-2010
  • Table 94 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 95 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Table 96 Sports Nutrition, Category Rankings 2010

Vitamins and Dietary Supplements in Finland - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements saw healthy 3% current value growth in 2010, reaching sales of €126 million. The category continued to see active product launches and advertising. Targeting specific consumer groups, such as children or the elderly, bore fruit, as consumers were looking for tailor-made products to prevent or treat health problems. As the recession was still present and unemployment levels were high, consumers compared prices and quality.

Vitamins

Dietary Supplements

COMPETITIVE LANDSCAPE

  • Vitamins and dietary supplements is fragmented in Finland, with a very wide choice of products available, most of which are niche. Ferrosan continued to lead with a 17% share of value sales in 2010. This was due both to a large product portfolio, with brands present in many categories, and also to strong brands such as its best-seller Multi-Tabs. Multi-Tabs is indeed the most popular brand of vitamins and dietary supplements, holding a 10% share of retail value sales in 2010. Reader’s Digest chose the brand for the ninth time as Finland’s most trusted vitamin product in 2009. Ferrosan has been on the Finnish market for a long time and enjoys wide distribution through most pharmacies in Finland. The company’s brands are therefore well-known and trusted in Finland.

PROSPECTS

  • Vitamins and dietary supplements is predicted to see a constant value CAGR of 2% in the forecast period 2010-2015, reaching sales of €139 million in 2015. Constant value growth rates are predicted to continue to be positive and more dynamic than the review period CAGR. Growth will come from the health trend and growing interest in self-medication and preventative medicine, new launches and advertising campaigns. Other factors underpinning demand will include an ageing population, as well as the increasing occurrence of lifestyle-related illnesses, and the fact that both work and social lives are becoming more demanding. This will make products which claim to improve performance and prevent the ‘flu more appealing to Finnish consumers.

CATEGORY DATA

  • Table 97 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 98 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 99 Dietary Supplements by Positioning 2005-2010
  • Table 100 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 101 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 102 Vitamins Brand Shares by Value 2007-2010
  • Table 103 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 104 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 105 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 18 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in Finland - Category Analysis

HEADLINES

TRENDS

  • Weight management increased by 6% in current value terms, with sales reaching €27 million in 2010.This dynamic growth was due to the entry of the OTC obesity brand Alli into the Finnish market in 2009. Moreover, as obesity levels are high and still increasing in Finland, and as consumers have become more worried about their wellbeing and appearance, weight management products benefited. Advertising was also significant in this category, as well as good availability.

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline led weight management with a 22% share of value sales in 2010.This was due to the heavily advertised, first and only OTC obesity brand Alli, which was launched in 2009. Sales grew intensively after its launch, and Alli became the 11th best-selling OTC medicines in Finland in 2010. Axellus followed in second position with a 18% share of value sales. This position is mainly due to its strength in the largest category, meal replacement slimming, in which its popular and well-known Nutrilett brand is doing very well. After Alli, Nutrilett is the leading weight management product sold in Finland.

PROSPECTS

  • Weight management is predicted to increase by a constant value CAGR of 2% in the forecast period 2010-2015, reaching sales of €30 million in 2015. Growing levels of obesity, increased body-consciousness, less time for exercise and strong advertising will help to push value sales. Consumers are also attracted to the idea that weight management products offer a “short cut” in order to lose a few kilos more easily and even faster.

CATEGORY DATA

  • Table 106 Sales of Weight Management: Value 2005-2010
  • Table 107 Sales of Weight Management: % Value Growth 2005-2010
  • Table 108 Weight Management Company Shares 2006-2010
  • Table 109 Weight Management Brand Shares 2007-2010
  • Table 110 Forecast Sales of Weight Management: Value 2010-2015
  • Table 111 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Wound care increased by 2% in current value terms, with sales reaching €12 million in 2010. New product developments continued to push sales. Wound care products are also present in virtually all households, and consumers stock them up for emergencies. What also helped to push sales was wound care products specifically designed for different functions and target groups, such as wound care for toes, blisters, knees, children, or people active in sports. Silver was also a trendy ingredient with antibacterial properties in sticking plasters, which generated consumer interest.

COMPETITIVE LANDSCAPE

  • Beiersdorf continued to strengthen its leading position in wound care to a 39% share of value sales in 2010. Its lead is a result of the well-known and trusted Hansaplast family of products. Hansaplast is available in a range of various formats, and is present in most retail chains. The brand was also the most active in terms of new launches, introducing several more sophisticated products over the review period. It also enjoyed prime shelf positioning, and was actively marketed and advertised.

PROSPECTS

  • Wound care is predicted to increase by a CAGR of 1% in constant value terms over the forecast period 2010-2015, reaching sales of €13 million in 2015. This slow growth will come from maturity and already high penetration. Also, recovery from the recession and competition between brands and private label is expected to lead to modest value growth.

CATEGORY DATA

  • Table 112 Sales of Wound Care by Category: Value 2005-2010
  • Table 113 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 114 Wound Care Company Shares by Value 2006-2010
  • Table 115 Wound Care Brand Shares by Value 2007-2010
  • Table 116 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 117 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Cranberry
            • Isoflavones
            • Spirulina
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Benecol
            • Lecithin
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking incidence

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report